BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...to about $50 million. Existing investors Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling Ventures...
BioCentury | Nov 30, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling Ventures...
BioCentury | Nov 29, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling Ventures...
BioCentury | Oct 6, 2017
Financial News

SpecificiT completes seed financing

...Inc. (Montreal, Quebec) said it completed an undisclosed seed financing in late August led by Sanderling Ventures...
...allogeneic hematopoietic stem cell transplantation. SpecificiT also said it named Pierre Beauparlant, venture partner at Sanderling Ventures...
BioCentury | Jul 28, 2017
Financial News

PreciThera raises C$36M series A

...$28.6 million) on July 27 in an oversubscribed series A round led by Arix Bioscience. Sanderling Ventures...
BioCentury | Jul 27, 2017
Financial News

PreciThera raises C$36M in series A

...raised C$36 million ($28.6 million) in an oversubscribed series A round led by Arix Bioscience. Sanderling Ventures...
BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...Family Office, AstraZeneca plc, other undisclosed investors DalCor Pharma U.K. Ltd. (U.K.) Series B $100.0 Sanderling Ventures...
BioCentury | Dec 1, 2016
Emerging Company Profile

Safe arrest

...Paul Scherrer Institute Corporate partners: N/A Number of employees: 3 Funds raised: Undisclosed Investors: Sanderling Ventures...
BioCentury | Nov 18, 2016
Financial News

Glycomine completes venture financing

...Glycomine raised $12 million in a series A round led by Sanderling Ventures . Chiesi Ventures and...
BioCentury | Nov 16, 2016
Financial News

Glycomine raises $12M in series A round

...Glycomine Inc. (San Francisco, Calif.) raised $12 million in a series A round led by Sanderling Ventures...
Items per page:
1 - 10 of 70
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...to about $50 million. Existing investors Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling Ventures...
BioCentury | Nov 30, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling Ventures...
BioCentury | Nov 29, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling Ventures...
BioCentury | Oct 6, 2017
Financial News

SpecificiT completes seed financing

...Inc. (Montreal, Quebec) said it completed an undisclosed seed financing in late August led by Sanderling Ventures...
...allogeneic hematopoietic stem cell transplantation. SpecificiT also said it named Pierre Beauparlant, venture partner at Sanderling Ventures...
BioCentury | Jul 28, 2017
Financial News

PreciThera raises C$36M series A

...$28.6 million) on July 27 in an oversubscribed series A round led by Arix Bioscience. Sanderling Ventures...
BioCentury | Jul 27, 2017
Financial News

PreciThera raises C$36M in series A

...raised C$36 million ($28.6 million) in an oversubscribed series A round led by Arix Bioscience. Sanderling Ventures...
BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...Family Office, AstraZeneca plc, other undisclosed investors DalCor Pharma U.K. Ltd. (U.K.) Series B $100.0 Sanderling Ventures...
BioCentury | Dec 1, 2016
Emerging Company Profile

Safe arrest

...Paul Scherrer Institute Corporate partners: N/A Number of employees: 3 Funds raised: Undisclosed Investors: Sanderling Ventures...
BioCentury | Nov 18, 2016
Financial News

Glycomine completes venture financing

...Glycomine raised $12 million in a series A round led by Sanderling Ventures . Chiesi Ventures and...
BioCentury | Nov 16, 2016
Financial News

Glycomine raises $12M in series A round

...Glycomine Inc. (San Francisco, Calif.) raised $12 million in a series A round led by Sanderling Ventures...
Items per page:
1 - 10 of 70